Christine Deuschel Cornioley
Directeur/Bestuurslid bij Biocartis SA
Oorsprong van het eerstegraads netwerk van Christine Deuschel Cornioley
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Biocartis SA
 Biocartis SA Medical SpecialtiesHealth Technology Biocartis SA develops molecular diagnostic solutions. It focuses on Oncology. The firm’s products include Idylla and Oncology assays and mutation tests. It also provides instant access to personalized medicine for patients. The company was founded by Rudi Pauwels in 2007 and is headquartered in Lausanne, Switzerland.
19
| Subsidiary | Medical Specialties | 19 |
University of Fribourg
18
| College/University | Other Consumer Services | 18 |
Debiopharm International SA
 Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland.
13
| Subsidiary | Pharmaceuticals: Major | 13 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Christine Deuschel Cornioley via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| BIOCARTIS GROUP NV | Medical Specialties | Director/Board Member Director/Board Member Chairman Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer Chief Operating Officer Director/Board Member | |
| Ghent University | College/University | Undergraduate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree Doctorate Degree | |
| MDXHEALTH SA | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member Chairman | |
| Katholieke Universiteit Leuven | College/University | Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree | |
| University of Antwerp | College/University | Graduate Degree Graduate Degree Graduate Degree | |
Fujirebio Europe NV
 Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Medical Specialties | Founder Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
MyCartis NV
 MyCartis NV BiotechnologyHealth Technology MyCartis NV develops technologies for healthcare personalization needs. It offers Evalution, a multiplex analysis platform to develop protein and nucleic-acid based clinical biomarkers. The company provides disruptive solutions in the fields of clinical and translational research for various applications in the detection of proteins and nucleic acids, such as sandwich immunoassays, antibody assays, genotyping assays, and mutation analysis assays to customers and partners. It offers products for various disease areas, including cell signalling, cardiovascular, oncology, and preeclampsia. The company was founded by Koen Kas in August 2004 and is headquartered in Ghent, Belgium. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Debiopharm Innovation Fund /Management/
 Debiopharm Innovation Fund /Management/ Investment ManagersFinance Debiopharm Innovation Fund SA develops, manufactures, and markets diagnostic systems. It seeks to invest in the biotechnology, diagnostics, and pharmaceutical industries with a focus on biomarker development, and large molecule capabilities. The firm mission is to invest in innovative diagnostic companies developing platforms and content to complement in-house diagnostic activities, give insight into cutting-edge diagnostics and facilitate access to new technologies. The company was founded in 1979 and is headquartered in Fribourg, Switzerland. | Investment Managers | Director/Board Member Chief Executive Officer Director/Board Member | |
Intrexon ActoBiotics NV
 Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium. | Biotechnology | Director/Board Member Director/Board Member Chairman | |
Med Discovery SA
 Med Discovery SA BiotechnologyHealth Technology Med Discovery SA is a Swiss biopharmaceutical company that develops treatments for cancers. The private company was founded by David Luc Deperthes. | Biotechnology | Founder Corporate Officer/Principal | |
Immunexpress Pty Ltd.
 Immunexpress Pty Ltd. Medical SpecialtiesHealth Technology Immunexpress Pty Ltd. engages in creating molecular diagnostics for sepsis. The company was founded by Roslyn Brandon, Mervyn Rees Thomas and Richard Bruce Brandon and in 2006 and is headquartered in Toowong, Australia. | Medical Specialties | Director/Board Member Director/Board Member | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| ABLYNX | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| University of Zurich | College/University | Graduate Degree Undergraduate Degree | |
| University of Lausanne | College/University | Corporate Officer/Principal Undergraduate Degree | |
FlandersBio vzw
 FlandersBio vzw Miscellaneous Commercial ServicesCommercial Services FlandersBio vzw is a life sciences cluster organization based in Flanders, Belgium. FlandersBio creates value by organizing networking and training activities, supporting internationalization, providing services, and building expertise. The Belgian company was founded by Jean Marie Stassen. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
| GALAPAGOS NV | Biotechnology | Chairman Founder | |
deVGen NV
 deVGen NV BiotechnologyHealth Technology deVGen NV provides biotechnology services for the pharmaceutical and agrochemical industries. It innovates in crop protection research and environment induced stress tolerance for its own crops and provides technology to corporate partners. The firm produces and sells its hybrid seeds in field crops such as rice, sunflower, sorghum and pearl millet in the Indian subcontinent and Southeast Asia. The company was founded by Thierry Bogaert on September 10, 1997 and is headquartered in Ghent, Belgium. | Biotechnology | Director/Board Member Director/Board Member | |
Advent Venture Partners LLP
 Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor Private Equity Investor | |
Helvetia Insurance Switzerland
 Helvetia Insurance Switzerland Insurance Brokers/ServicesFinance Part of Helvetia Holding AG, Helvetia Insurance Switzerland is a Swiss insurance company. The company is based in St. Gallen, Switzerland. The CEO of the company is Martin Jara. | Insurance Brokers/Services | Chief Executive Officer | |
| Swisscanto Vested Benefits Foundation | Corporate Officer/Principal | ||
Grand Casino Luzern AG
 Grand Casino Luzern AG Media ConglomeratesConsumer Services Grand Casino Luzern AG owns and operates casinos. It offers bars, dinner and casino, hotel and casino and rooms for corporate events. The company was founded in 1882 and is headquartered in Lucerne, Switzerland. | Media Conglomerates | Director/Board Member | |
| Duke University School of Law | College/University | Graduate Degree | |
| HELVETIA HOLDING AG | Multi-Line Insurance | Chief Executive Officer | |
Prevo-System AG
 Prevo-System AG Packaged SoftwareTechnology Services Prevo-System AG develops software for insurance companies. The private company is based in Basel, Switzerland. | Packaged Software | Director/Board Member | |
| Coop Rechtsschutz AG | Director/Board Member | ||
| SCHWEIZERISCHE NATIONAL VERSCHRNGS GS AG | Multi-Line Insurance | Director/Board Member | |
| Helvetia Schweizerische Versicherungsgesellschaft (Invt Mgmt) | Investment Managers | Chief Executive Officer | |
| Swisscanto Supra Cantonal Banks Collective Foundation | Director/Board Member | ||
Chroma Therapeutics Ltd.
 Chroma Therapeutics Ltd. BiotechnologyHealth Technology Chroma Therapeutics Ltd. engages in the discovery and development of therapies for the treatment of cancer and inflammation. It focuses on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell accumulation approaches. The firm uses chromatin biology, drug accumulation approaches to discover and develop cancer, inflammation treatments and small molecule drugs. The company was founded by David Allis, Alan Hornsby Davidson, Alan Hastings Drummond, Anthony Kouzarides and Paul Workman in September 2001 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Chairman | |
| Casino Online AG | Director/Board Member | ||
| Swiss Insurance Association | Director/Board Member | ||
| EVOLVA HOLDING SA | Food: Specialty/Candy | Director/Board Member | |
International AIDS Vaccine Initiative, Inc.
 International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
Lonza AG
 Lonza AG BiotechnologyHealth Technology Lonza AG engages in the research in as well as development, production, and distribution of chemical products and materials. The firm also carries out investment and lending transactions. The company was founded on December 7, 1897 and is headquartered in Visp, Switzerland. | Biotechnology | Corporate Officer/Principal | |
| Lonza Arena AG | Director/Board Member | ||
| Hans Kalbermatten Thermalbad AG | Chairman | ||
PolyPeptide Laboratories Holding (PPL) AB
 PolyPeptide Laboratories Holding (PPL) AB Financial ConglomeratesFinance PolyPeptide Laboratories Holding (PPL) AB manufactures commercial therapeutic peptides. The firm offers polypeptide, custom peptide synthesis, peptide synthesis, and generic peptide. The company was founded in 1996 and is headquartered in Malmo, Sweden. | Financial Conglomerates | Director/Board Member | |
Siegfried AG
 Siegfried AG Chemicals: AgriculturalProcess Industries Founded in 1873, Siegfried AG is a chemical product manufacturing company. The company is based in Zofingen, Switzerland and is a part of Siegfried Holding AG. | Chemicals: Agricultural | Director/Board Member | |
| POLYPEPTIDE GROUP AG | Biotechnology | Director/Board Member | |
| Escientia Switzerland AG | Chairman | ||
Deccan Fine Chemicals (India) Pvt Ltd.
 Deccan Fine Chemicals (India) Pvt Ltd. Chemicals: SpecialtyProcess Industries Deccan Fine Chemicals (India) Pvt Ltd. engages in custom manufacturing of active ingredients and advanced intermediates for agro chemical, fine, and specialty chemical sectors. Its products are used in business areas such as crop protection, and pharmaceutical and animal health. The company was founded in 2008 is headquartered in Hyderabad, India. | Chemicals: Specialty | Director/Board Member | |
| SIEGFRIED HOLDING AG | Pharmaceuticals: Major | Director/Board Member | |
Stiftung Avenir Suisse
 Stiftung Avenir Suisse Investment Trusts/Mutual FundsMiscellaneous Stiftung Avenir Suisse develops ideas for the sociopolitical and economic development of Switzerland. It comprises of companies and private individuals from all economic branches and regions of Switzerland. The company was founded in 1999 and is headquartered in Zurich, Switzerland. | Investment Trusts/Mutual Funds | Director/Board Member | |
| LONZA GROUP AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SGS SA | Miscellaneous Commercial Services | Corporate Officer/Principal |
Statistieken
Internationaal
| Zwitserland | 28 |
| België | 16 |
| Verenigde Staten | 4 |
| Verenigd Koninkrijk | 3 |
| Australië | 2 |
Sectoraal
| Health Technology | 19 |
| Consumer Services | 9 |
| Finance | 9 |
| Commercial Services | 4 |
| Process Industries | 3 |
Operationeel
| Director/Board Member | 224 |
| Corporate Officer/Principal | 92 |
| Chairman | 51 |
| Chief Executive Officer | 34 |
| Graduate Degree | 33 |
Sterkste connecties
| Insiders | |
|---|---|
| Raj Bhikhu Parekh | 50 |
| Rudi Mariën | 31 |
| Christoph Caviezel | 28 |
| Staf van Reet | 22 |
| Rudi Pauwels | 19 |
| Philipp Robert Gmür | 19 |
| Ruth Devenyns | 18 |
| Romeo Cerutti | 18 |
| Domenico Valerio | 15 |
| Peter Piot | 14 |
| Jürg Roland Greter | 14 |
| Beat In-Albon | 13 |
| Jean-Christophe Deslarzes | 12 |
| Thomas Wayne Gibbs | 11 |
| Renata Jungo Brüngger | 11 |
- Beurs
- Insiders
- Christine Deuschel Cornioley
- Bedrijfsconnecties
